Jeffrey Brian McGroarty - 07 Jul 2021 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
Chief Financial Officer
Signature
/s/ Jeffrey McGroarty
Issuer symbol
ANVS
Transactions as of
07 Jul 2021
Net transactions value
$0
Form type
4
Filing time
09 Jul 2021, 18:28:24 UTC
Next filing
08 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANVS Stock Option (right to buy) Award $0 +14,000 $0.000000 14,000 07 Jul 2021 Common Stock 14,000 $102.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest in eight substantially equal quarterly installments beginning October 7, 2021, provided that the reporting person continues to be employed by the issuer on the applicable vesting date.